menu
    • menu

    Company profile for Neuren Pharmaceuticals

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Neuren is developing new therapies for neurodevelopmental disorders with high unmet need. Neuren Pharmaceuticals (ASX: NEU) is developing new therapies for debilitating neurodevelopmental disorders that are characterised by impaired connections and signalling between brain cells. Neuren Pharmaceuticals (ASX: NEU) is developing new therapies for debilitating neurodevelopmental disorders that are characterised by impaired connec...
    Neuren is developing new therapies for neurodevelopmental disorders with high unmet need. Neuren Pharmaceuticals (ASX: NEU) is developing new therapies for debilitating neurodevelopmental disorders that are characterised by impaired connections and signalling between brain cells. Neuren Pharmaceuticals (ASX: NEU) is developing new therapies for debilitating neurodevelopmental disorders that are characterised by impaired connections and signalling between brain cells. Neuren is progressing the non-clinical studies required prior to commencing clinical trials in 2020.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Neuren PharmaceuticalsAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    Neuren Pharmaceuticals Limited Suite 201, 697 Burke Road Camberwell VIC 3124
    Telephone
    Telephone
    +61 (3) 9092 0480
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.neurenpharma.com/IRM/content/default.aspx
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neuren-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Neuren's NNZ-2591 shows benefit in rare neurodevelopmental disorder
    Neuren's NNZ-2591 shows benefit in rare neurodevelopmental disorder

    28 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neuren-phase-2-trial-shows-significant-improvements-in-pitt-hopkins-syndrome-302155942.html#:~:text=Neuren\\\'s%20second%20drug%20candidate%2C%20NNZ,syndrome%20and%20Pitt%20Hopkins%20syndrome

    PR NEWSWIRE
    28 May 2024
    Share Share
    Neuren Phase 2 trial shows significant improvements in Pitt Hopkins syndrome
    Neuren Phase 2 trial shows significant improvements in Pitt Hopkins syndrome

    27 May 2024

    // BIOSPACE

    https://www.biospace.com/article/releases/neuren-phase-2-trial-shows-significant-improvements-in-pitt-hopkins-syndrome/

    BIOSPACE
    27 May 2024
    Share Share
    The Neuren Pharmaceuticals (ASX:NEU) share price has soared 102%
    The Neuren Pharmaceuticals (ASX:NEU) share price has soared 102%

    21 Dec 2021

    // FOOL

    https://www.fool.com.au/2021/12/22/the-neuren-pharmaceuticals-asxneu-share-price-has-soared-102-so-far-this-month-heres-why/

    FOOL
    21 Dec 2021
    Share Share
    Neuren submits IND application for NNZ-2591 in Phelan-McDermid syndrome
    Neuren submits IND application for NNZ-2591 in Phelan-McDermid syndrome

    21 Sep 2021

    // THEMARKETHERALD

    https://themarketherald.com.au/neuren-pharmaceuticals-asxneu-submits-ind-for-nnz-2591-in-pms-treatment-2021-09-21/?__cf_chl_jschl_tk__=pmd_MtY5TZwUD52nEpamlv0on6rYyDKKrRhXCCEk85gXsAU-1632296237-0-gqNtZGzNAjujcnBszQil

    THEMARKETHERALD
    21 Sep 2021
    Share Share
    ACADIA announce Rare Pediatric Disease Designation for Trofinetide
    ACADIA announce Rare Pediatric Disease Designation for Trofinetide

    09 Mar 2020

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/25/15561/acadia-neuren-pharma-announce-rare-pediatric-disease-designation-for-trofinetide.html

    BIOSPECTRUM ASIA
    09 Mar 2020
    Share Share
    ACADIA & Neuren Announce Rare Pediatric Disease Designation for Trofinetide
    ACADIA & Neuren Announce Rare Pediatric Disease Designation for Trofinetide

    04 Mar 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200303006075/en/ACADIA-Pharmaceuticals-Neuren-Pharmaceuticals-Announce-Rare-Pediatric/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==

    BUSINESSWIRE
    04 Mar 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search